User login
Back to top

Therapy and response

Displaying 5 results from 5 total publications.

Martinez-Calle et al. 2021.

Systemic ALCL Treated in Routine Clinical Practice: Outcomes Following First-Line Chemotherapy from a Multicentre Cohort

Nicolas Martinez-Calle,  Amy A. Kirkwood,  Maxine Lamb,  Alex Smith,  Jahanzaib Khwaja,  Kate Manos,  Caroline Shrubsole,  Nicola Gray,  Katharine Lewis,  Ann Tivey,  Mark J. Bishton,  Eliza Hawkes,  Matthew J. Ahearne,  Wendy Osborne,  Graham P. Collins,  Timothy Illidge,  Kim M. Linton,  Kate Cwynarski,  Cathy Burton,  Christopher P. Fox.

Advances in Therapy

Wilson et al. 2019.

Frontline management of nodular lymphocyte predominant Hodgkin lymphoma – a retrospective UK multicentre study

Matthew R. Wilson,  Timothy Bagguley,  Alexandra Smith,  Eve Roman,  Russell Patmore,  Katharine Hanlon,  Mike Leach,  Mark Bishton,  Cathy Burton,  Pam McKay.

British Journal of Haematology
Volume: 186, Issue: 6, Pages: 214-217.

McCulloch et al. 2018.

Receiving treatment at a specialist centre confers an overall survival benefit for patients with mantle cell lymphoma

Rory McCulloch,  Alexandra Smith,  Nicola Crosbie,  Russell Patmore,  Simon Rule.

British Journal of Haematology
Volume: 185, Issue: 5, Pages: 1002-1004.

Smith et al. 2018.

Impact of novel therapies for mantle cell lymphoma in the real world setting: a report from the UK's Haematological Malignancy Research Network (HMRN)

Alexandra Smith,  Eve Roman,  Simon Appleton,  Debra Howell,  Rod Johnson,  Cathy Burton,  Russell Patmore.

British Journal of Haematology
Volume: 181, Issue: 2, Pages: 215-228.

Smith et al. 2014.

Determinants of survival in patients with chronic myeloid leukaemia treated in the new era of oral therapy: findings from a UK population-based patient cohort

A. G. Smith,  D. Painter,  D. A. Howell,  P. Evans,  G. Smith,  R. Patmore,  A. Jack,  E. Roman.

BMJ open
Volume: 4, Issue: 1, Pages: e004266.